Kevin Whelan
Overview
Explore the profile of Kevin Whelan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
193
Citations
5381
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rabheru R, Langan A, Merriweather J, Connolly B, Whelan K, Bear D
Am J Clin Nutr
. 2025 Jan;
121(3):703-723.
PMID: 39746396
Background: Surviving critical illness leads to prolonged physical and functional recovery with both nutritional and physical rehabilitation interventions for prevention and treatment being investigated. Nutritional status and adequacy may influence...
2.
Wyatt N, Watson H, Young G, Doona M, Tilling N, Allerton D, et al.
EBioMedicine
. 2025 Jan;
112:105550.
PMID: 39742562
Background: Large-scale multicentre studies are needed to understand complex relationships between the gut microbiota, health and disease. Interrogating the mucosal microbiota may identify important biology not captured by stool analysis....
3.
Mancell S, Dhawan A, Geaney G, Ayis S, Whelan K
Clin Nutr
. 2024 Dec;
44:134-146.
PMID: 39667195
Background And Aims: Infants with biliary atresia experience gastrointestinal malabsorption of long-chain triglycerides and are commonly supplemented with medium-chain triglyceride (MCTs) that can be passively absorbed. The aim was to...
4.
Whelan K, Ford A, Burton-Murray H, Staudacher H
Lancet Gastroenterol Hepatol
. 2024 Nov;
9(12):1147-1161.
PMID: 39521003
Diet is a cornerstone in the management of irritable bowel syndrome (IBS). There is evidence of efficacy across the spectrum of dietary management strategies, including some supplements (eg, specific fibres),...
5.
Whelan K, Alexander M, Gaiani C, Lunken G, Holmes A, Staudacher H, et al.
Nat Microbiol
. 2024 Oct;
9(11):2785-2794.
PMID: 39478082
Diet is a major determinant of the gastrointestinal microbiome composition and function, yet our understanding of how it impacts the efficacy of prebiotics and probiotics is limited. Here we examine...
6.
Jiang C, Godoy-Brewer G, Rodriguez A, Graff E, Quintero M, Leavitt J, et al.
Gastro Hep Adv
. 2024 Sep;
3(6):773-782.
PMID: 39280907
Background And Aims: Anxiety over food choices and symptoms related to food consumption diminish quality of life (QoL) in inflammatory bowel disease (IBD) patients. However, the specific factors that impact...
7.
Ananthakrishnan A, Whelan K, Allegretti J, Sokol H
Clin Gastroenterol Hepatol
. 2024 Jul;
23(3):406-418.
PMID: 38992408
Inflammatory bowel disease (IBD) comprises chronic and relapsing disorders of the gastrointestinal tract, characterized by dysregulated immune responses to the gut microbiome. The gut microbiome and diet are key environmental...
8.
Wyatt N, Watson H, Anderson C, Kennedy N, Raine T, Ahmad T, et al.
BMJ Open
. 2024 Apr;
14(4):e073639.
PMID: 38631839
Introduction: Characterised by chronic inflammation of the gastrointestinal tract, inflammatory bowel disease (IBD) symptoms including diarrhoea, abdominal pain and fatigue can significantly impact patient's quality of life. Therapeutic developments in...
9.
Ni Lochlainn M, Bowyer R, Moll J, Garcia M, Wadge S, Baleanu A, et al.
Nat Commun
. 2024 Feb;
15(1):1859.
PMID: 38424099
Studies suggest that inducing gut microbiota changes may alter both muscle physiology and cognitive behaviour. Gut microbiota may play a role in both anabolic resistance of older muscle, and cognition....
10.
Whelan K, Bancil A, Lindsay J, Chassaing B
Nat Rev Gastroenterol Hepatol
. 2024 Feb;
21(6):406-427.
PMID: 38388570
Ultra-processed foods (UPFs) and food additives have become ubiquitous components of the modern human diet. There is increasing evidence of an association between diets rich in UPFs and gut disease,...